Subcutaneous neonatal administration of recombinant factor IX (BeneFix™) induces immune tolerance in hemophilia B dogs - Russell, DE; Stewart, PF; Elwell, DR; Nichols, TC; Bellinger, DA; Brinkhous, KM; Rup, BJ; Keith, JC; Leitermann, K; McCarthy, KP; Schaub, RG; Read, MS (Blood, 1997)
Suppl 2662.